Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Carprieve 50 mg/ml Solution recalled over impurity concerns
The VMD has issued a product defect recall alert for Carprieve 50 mg/ml Solution for Injection for Cattle.
The problem affects a limited number of batches.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Carprieve 50 mg/ml Solution for Injection for Cattle, manufactured by Norbrook Laboratories Ltd.

In a press release, the VMD writes: 'We wish to make veterinary surgeons aware that Norbrook Laboratories Ltd has issued a recall for the product Carprieve 50 mg/ml Solution for Injection for Cattle as a precautionary measure.

'During stability monitoring analysis of the product, an impurity was detected which exceeded the specification for an individual impurity. The impurity was isolated, and the best estimate of identity indicated that the impurity is carprofen related.

'The problem affects a limited number of batches and is identifiable through quality control testing. The concentration of the process impurity does not increase over time'

The recall affects the following batch numbers only:

  9371-90
  9372-90
  9373-91
  0105-90
   
In light of this recall, Norbrook Laboratories is in the process of contacting wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products.

Further information regarding the recall can be obtained from Mr Gary Mckee on 0044 2830 264435 or by email to gary.mckee@norbrook.co.uk

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.